| ACovPid | Against Virus | Inhibition Value Type | Inhibitory Effect | Inhibitory Unit | Target Domain Name | Detail |
|---|---|---|---|---|---|---|
| ACoVP100321 | EC50 | 0.45 ± 0.13 | µM | more | ||
| ACoVP100322 | EC50 | 2.93 ± 0.95 | µM | more | ||
| ACoVP100323 | EC50 | 0.15 ± 0.06 | µM | HR1 domain of MERS-CoV (Betacoronavirus England 1) | more | |
| ACoVP100324 | EC50 | 0.13 | µM | more | ||
| ACoVP100325 | Severe acute respiratory syndrome coronavirus 2 (2019-nCoV) (SARS-CoV-2) : 2697049 | HR1 domain of SARS-CoV-2 | more | |||
| ACoVP100326 | Severe acute respiratory syndrome coronavirus 2 (2019-nCoV) (SARS-CoV-2) : 2697049 | IC50 | 0.022 ± 0.005 | µM | HR2 domain of SARS-CoV | more |
| ACoVP100327 | Severe acute respiratory syndrome coronavirus 2 (2019-nCoV) (SARS-CoV-2) : 2697049 | IC50 | 0.025 ± 0.002 | µM | HR2 domain of SARS-CoV | more |
| ACoVP100328 | Severe acute respiratory syndrome coronavirus 2 (2019-nCoV) (SARS-CoV-2) : 2697049 | IC50 | 0.015 ± 0.002 | µM | HR2 domain of SARS-CoV | more |
| ACoVP100329 | Severe acute respiratory syndrome coronavirus 2 (2019-nCoV) (SARS-CoV-2) : 2697049 | IC50 | 0.033 ± 0.013 | µM | HR2 domain of SARS-CoV | more |
| ACoVP100330 | Severe acute respiratory syndrome coronavirus 2 (2019-nCoV) (SARS-CoV-2) : 2697049 | IC50 | >5 | µM | HR2 domain of SARS-CoV | more |
| ACoVP100331 | Severe acute respiratory syndrome coronavirus 2 (2019-nCoV) (SARS-CoV-2) : 2697049 | IC50 | >5 | µM | HR2 domain of SARS-CoV | more |
| ACoVP100332 | Severe acute respiratory syndrome coronavirus 2 (2019-nCoV) (SARS-CoV-2) : 2697049 | IC50 | 0.017 ± 0.001 | µM | HR2 domain of SARS-CoV | more |
| ACoVP100333 | Severe acute respiratory syndrome coronavirus 2 (2019-nCoV) (SARS-CoV-2) : 2697049 | IC50 | 4.66 ± 1.565 | µM | HR2 domain of SARS-CoV | more |
| ACoVP100334 | Severe acute respiratory syndrome coronavirus 2 (2019-nCoV) (SARS-CoV-2) : 2697049 | IC50 | >5 | µM | HR2 domain of SARS-CoV | more |
| ACoVP100335 | Severe acute respiratory syndrome coronavirus 2 (2019-nCoV) (SARS-CoV-2) : 2697049 | IC50 | 33.74 ± 11.827 | µM | HR2 domain of SARS-CoV | more |
| ACoVP100336 | Severe acute respiratory syndrome coronavirus 2 (2019-nCoV) (SARS-CoV-2) : 2697049 | IC50 | 0.08 ± 0.017 | µM | HR2 domain of SARS-CoV | more |
| ACoVP100337 | Severe acute respiratory syndrome coronavirus 2 (2019-nCoV) (SARS-CoV-2) : 2697049 | IC50 | 0.947 ± 0.179 | µM | HR2 domain of SARS-CoV | more |
| ACoVP100338 | Severe acute respiratory syndrome coronavirus 2 (2019-nCoV) (SARS-CoV-2) : 2697049 | IC50 | 0.218 ± 0.063 | µM | HR2 domain of SARS-CoV | more |
| ACoVP100339 | Severe acute respiratory syndrome coronavirus 2 (2019-nCoV) (SARS-CoV-2) : 2697049 | IC50 | >25 | µM | HR2 domain of SARS-CoV | more |
| ACoVP100340 | Severe acute respiratory syndrome coronavirus 2 (2019-nCoV) (SARS-CoV-2) : 2697049 | IC50 | >25 | µM | HR2 domain of SARS-CoV | more |